Background: Respiratory support in very preterm infants is often a life-saving procedure and several techniques are available. There is lack of data on the current use of these techniques. Methods and aim: We analyzed a cohort of infants <30 weeks gestation or < 1501 g birth weight, enrolled in the Italian Neonatal Network in 2009 and 2010 (n = 8297, mean gestation = 29.3 weeks, mean birth weight = 1089 g) to ascertain the use of several techniques. We also conducted a questionnaire survey of all neonatal units adhering to the Italian Neonatal Network, inquiring about preferred methods of respiratory support. Results: Conventional ventilation was used in 53% of these infants, high frequency ventilation in 15.8%, CPAP in 71.6%, and surfactant in 56.2%. Huge variations were observed between hospitals for all techniques studied. The survey of centres showed that all respondents considered non-invasive ventilation the first-intention treatment for these infants. In case of need of tracheal intubation and mechanical ventilation, two hospitals said they used IPPV/ IMV; 20 synchronized IPPV/IMV; 25 "volume guarantee"; and 10 hospitals used HFV as a first intention treatment (in five hospital for all infants, and in other five hospitals, depending upon birth weight/gestation. Conclusions: This study provides large scale, up to date results of the current methods of respiratory support in very preterm infants in Italy. Huge variations between hospitals, only partly explained by the paucity of evidence-based data, are apparent. These differences point to the possibility of implementing "potentially better practices" with the aim of reducing unwanted, physician-related variation.
Respiratory support in very preterm infants is often a life-saving procedure. In the last several years, a great number of techniques have been proposed and used to treat respiratory insufficiency in neonates, including both invasive (e.g. "conventional" mechanical ventilation, both synchronized and non-synchronized, with and without volume guarantee; time-cycled and flow-cycled or high frequency ventilation [HFV] ) and "non-invasive" (e.g. nasal continuous positive airway pressure (CPAP), nasal intermittent mandatory ventilation, with high flow nasal cannulae) techniques.
Most of the evidence regarding differences between different techniques stems from small studies, often with short term outcomes. On the contrary, large randomized controlled trials and systematic reviews mostly prove equivalence in short and long term outcomes among the newborns treated with different respiratory assistance techniques [1] [2] [3] [4] [5] .
Ideally, the type of respiratory support should match the degree of respiratory compromise, with a gradient from lesser to greater invasiveness, but there is large room for individual opinions in the matter of ventilation/respiratory support for the preterm infant. As a consequence, the "market share" of each technique is unknown, and there are very little epidemiological data available from scientific literature.
One way to approach this problem is asking directors of clinical units about their "standard" management of preterm infants. A famous example is the "eight centres" survey that put emphasis on CPAP [6] ; some years ago, Sharma and Greenough [7] conducted a survey among UK chiefs of neonatal units about their preferred management. These surveys can be extremely useful in understanding what the opinions of senior clinicians/ opinion leaders are, but they do not report data on the current methods of providing respiratory support in neonates.
In literature there are no suitable, recent estimates of how these various techniques are currently used in neonatal intensive care units (NICUs). The availability of data from large neonatal networks allows an objective assessment of use of various techniques.
Given the high impact of respiratory techniques in neonatology, and the lack of information about their use, to learn more objective data about current respiratory management of very preterm infants, we adopted a dual strategy: (1) an analysis of the data of the respiratory support offered to individual very preterm neonates enrolled in the Network Neonatale Italiano (Italian Neonatal Network, INN), and (2) a brief survey of the protocols in use in the neonatal units adhering to the INN.
The aim of this study is to describe the current respiratory management of very preterm neonates in Italy. days, or neonates with a birth weight <1501 g, admitted to any of the centres within 1 month of age.
In 2009, 73 centres participated, and in 2010 a further 10 contributed data (Total = 83). Although the exact number of NICUs in Italy is not known, about 110 centres are believed to be a correct estimate. Thus, the neonatal units participating in the INN care vast majority of very preterm infants in Italy, and in some Italian regions the coverage is complete. Therefore, the INN represents an important source of data that reflect neonatal management in Italy.
All definitions are those of the VON (www.vtoxford.org); briefly, in addition to anthropometric measures such as gestational age (GA), birth weight (BW), sex, etc, the following variables are collected for each infant: respiratory management in the delivery room (use of oxygen, bag-and-mask ventilation, intubation, surfactant administration) and in the ward. As far as ventilatory support is concerned, the database collects data on procedures such as oxygen supplementation; use of CPAP, of CPAP before intubation; of high flow nasal cannulae; of nasal intermittent mandatory ventilation (IMV)/synchronized intermittent mandatory ventilation (SIMV); of conventional ventilation; of HFV; and surfactant administration in the ward. Bronchopulmonary dysplasia (BPD) refers to the oxygen requirement at 36 weeks.
The data of the INN is compared with the data from the whole VON in 2010 (more than 57 000 infants with the same characteristics), obtained from the web-based system "Nightingale".
Questionnaire analysis
The questionnaire (available on request) was prepared by PT and sent by email to all chiefs of neonatal units adhering to the INN, with reminders in case of non-response. It included questions on the existence in the unit of protocols detailing the approach to respiratory diseases in the neonates, and which type of respiratory support was chosen as first line therapy and whether HFV was used for rescue in the event of a failure of conventional ventilation. Fifty-seven hospitals (69%) responded.
Results
The study included 8297 infants (3981 in 2009, and 4316 in 2010), treated in 83 hospitals. For the purpose of this study, we only excluded infants dying in the delivery room (n = 73).
The mean GA was 29.3 weeks (median = 29.4, SD = 2.96) and the mean BW was 1089 g (median = 1130, SD = 302).
Mortality was 14.2%, and BPD (supplemental oxygen at 36 weeks postmenstrual age) 13.9% (15.5% in infants <33 weeks). Table I shows the percentage of infants receiving any of the listed procedures, comparing the data with the data from the VON. The frequency of use of most procedures is lower in Italian hospitals in comparison to the VON.
Given that INN recruits infants above 30 weeks GA only if they are below 1501 g BW, with an increase of small for gestational age (SGA) infants with increasing GA, these procedures are displayed in Table II for infants of 23-29 weeks only (the data for this population is complete in the database). The GA-associated decrease in the use of procedures is clearly apparent. Table III provides details regarding a particular procedure are shown; i.e. a comparison in the time to surfactant administration in infants of 23-29 weeks between INN and rest of the VON. For all GA weeks considered, the percentage of infants treated with surfactant >2 h of age is always greater in Italy than in the VON, even for very preterm infants, where surfactant is almost universally administered (see Table II ).
Figures on the average use of various techniques even when split in weeks of GA, tell only part of the story, because variation across centres is conspicuous.
For six selected procedures (Delivery room intubation; delivery room surfactant; any mechanical ventilation, HFV, CPAP before intubation, non-invasive ventilation), Figure 1 provides the mean use of each procedure for each of the 83 hospitals. The variation is very great for all procedures, indicating that the mean value reported in Tables I-III for all procedures is, in reality, an abstraction. Both the pattern, and the extent of variation differs across the procedures: the coefficient of variation is lower for non-invasive ventilation (0.17), ventilation (0.26) and delivery room intubation (0.36), than for CPAP before endotracheal intubation (ETT) (0.58), and is highest for HFV (0.86) and delivery room surfactant (0.89). Interestingly, the correlation between the mean use of techniques across hospitals (Table IV) shows that some techniques are not very correlated with one other. For instance, HFV is only associated with delivery room (DR) intubation (r = 0.31), but not with conventional ventilation (r = 0.02), i.e. hospitals that use more HFV do not use less conventional ventilation. NIV-only is negatively affected (as expected) by conventional ventilation (i.e. hospitals that ventilate more, use less NIV-only), but not with HFV (hospitals that use more HFV have the same number of infants managed non-invasively).
Considered together, this data suggest that it is difficult to ascribe this broad variation to differences in case-mix, and it likely represents a "physician-driven" variation.
As for the results of the questionnaire, of the 57 hospitals that responded to the questionnaire, six said they did not have a protocol for respiratory assistance and were excluded from further analysis; all the others said that they used "non-invasive" techniques first.
In the event of needing tracheal intubation and mechanical ventilation as a first-intention treatment, two hospitals said they used IPPV/IMV; 20 synchronized IPPV/IMV; 25 "volume guarantee"; and 10 hospitals used HFV (in five hospital for all infants, and in other five hospitals, depending upon BW/GA). (The figures do not add up to 51 because in some cases hospitals had a dual first choice).
As for rescue HFV, seven hospitals (among those that did not always use HFV as a first intention) responded that they did not use HFV as a rescue, while all the others did use HFV as rescue.
Discussion
To the best of our knowledge, this study represents the first large scale, current survey of actual techniques used to provide respiratory assistance to very preterm infants, admitted to intensive/ special care baby units in Italy in very recent years.
In fact, our conclusions rest on more than 8000 very preterm/ very small neonates assisted in 83 centres in 2009-2010. This data confirms that ventilatory assistance remains one of the most important and most used procedures for these infants. Focusing only on infants of 23-29 weeks demonstrates that, as expected, the number of infants receiving each treatment decreases with the GA. Of great interest, in light of the current trend towards a lower level of invasiveness, is the number of infants who are managed without "invasive" (i.e. without endotracheal tube positioning) techniques. While invasive ventilation is always used at the lower extreme of viability, our data show that at 29 weeks, only half of the infants require intubation and receive at least one dose of surfactant, while the other half is managed non-invasively. The comparison with the data of VON shows that, on the whole, Italian neonates are treated less invasively. In addition to the current description of use of various techniques, this study shows great variations in their use. This variation has been frequently reported [8] [9] [10] [11] [12] in studies on ventilation.
Of note, most of the procedures surveyed and employed (CPAP, mechanical ventilation, even HFV), can nowadays be considered "standard", and date back several years, so that these differences between hospitals cannot be due to a novelty of the idea of various techniques. Despite the long time that HFV, conventional mechanical ventilation, and nasal continuous positive airway pressure (NCPAP) have been available, the differences between the centres are striking, and probably reflect different approaches to the preterm infants with respiratory distress, i.e. physician-driven variation, rather than differences in case-mix.
The lack of solid data to guide therapeutic decisions is certainly an important cause of this variation [1] [2] [3] [4] [5] . However, also the lack of an attitude towards evidence-based approach to ventilation plays an important role.
We believe that the reason for these discrepancies is that the practice of neonatology has a large "handicraft" (as opposed to "engineered", scientific) component. In this scenario, different neonatal units put more emphasis on locally-developed protocols and "mindlines", building on historical experience developed over years (a "school" of thought) rather than trying to conform to objective recommendations. A telling example is the difference between INN and VON for the timing of surfactant administration. For very low GA infants at 24-26 weeks GA, surfactant is almost always used. Meta-analyses recommend prophylactic administration over rescue administration [13, 14] , and it is likely that by 2 h of age, such very small infants have "declared" themselves (i.e. those with a respiratory distress syndrome (RDS) requiring surfactant are recognizable). Yet, 14% of infants at 24 weeks GA are treated with surfactant beyond 2 h of age. Another example is that the number of units using first-intention HFV (and the number of infants treated with HFV) is much smaller than what one would expect knowing that -if anything -HFV is equal or better than "conventional" ventilation for preterm infants [4, 5] .
The survey conducted among chiefs of neonatal units helps us supplement the analysis of infants. In fact, it demonstrates that none of the respondents considers NIV unsuitable for a trial in infants. In practice, however, we can see that CPAP before intubation is used from 0% to about 80% of infants. As for the choice of invasive (with intubation) ventilation, only two hospitals used a non-synchronized "conventional" ventilation, five used HFV always, and the other five used HFV in some (smaller/ more immature) infants only. The vast majority of units used synchronized ventilation, with or without volume guarantee. In a survey carried out in the UK and published in 2007 [7] , only 2% of units chose CPAP as initial treatment of acute RDS, 2% used HFV, 22% used some form of synchronized ventilation, while non-synchronized conventional ventilation was chosen by 73%. The differences between years and between countries may explain these discrepancies.
It is, however, tempting to speculate that the low frequency of BPD observed in these infants is at least partly due to less invasive techniques.
This study had the obvious limitation that the VON (and INN) database does not include details about the duration of support, nor does it enable us to ascertain the time course of events (e.g. when ventilation is started and stopped, or what techniques are used after extubation), so neither the amount of resources absorbed nor the actual clinical trajectories of infants are known.
These data, however, form a basis for recognizing areas for potential improvement in ventilation given to preterm neonates. The great variation across hospitals in all the surveyed techniques points to the possibility of implementing "potentially better practices" (such as the widespread use of delivery room CPAP or gentle ventilation; reduced intubation at birth; greater use of HFV or low tidal volume ventilation, more consistent use of prophylactic surfactant in very tiny infants, etc.) with the aim of reducing unwanted, physician-related variation. The use of data impressively shows the power of large neonatal networks in identifying areas for potential improvement.
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